Rekvina Laboratories Limited (BOM:526075)
40.15
+1.88 (4.91%)
At close: May 26, 2026
Rekvina Laboratories Revenue
In the fiscal year ending March 31, 2026, Rekvina Laboratories had annual revenue of 12.65M INR. Rekvina Laboratories had revenue of 7.24M in the quarter ending March 31, 2026.
Revenue
12.65M
Revenue Growth
n/a
P/S Ratio
20.08
Revenue / Employee
2.53M
Employees
5
Market Cap
254.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.65M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Add-Shop E-Retail | 1.55B |
| ANG Lifesciences India | 862.13M |
| Deccan Health Care | 816.77M |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Gujarat Terce Laboratories | 483.98M |